Holland Reporter

Congressman Bill Huizenga (R-MI) has issued a statement following an agreement between the Trump Administration and Pfizer to reduce drug prices for Americans, including Medicaid recipients in Southwest Michigan and across the country. The announcement also included Pfizer's commitment to participate in TrumpRx.gov, a direct-to-consumer platform that will allow Americans to purchase medicines, including primary care treatments and some specialty brands from Pfizer, with potential savings of up to 85 percent and an average of 50 percent.

“This announcement from Pfizer will have a significant cost-savings impact on Medicaid recipients, seniors, and families across the United States,” said Congressman Bill Huizenga. “I applaud Pfizer for their leadership and working with the Trump Administration to lower prescription drug prices and make life-saving medications more affordable for Americans.”

“I have long called for the strengthening of our domestic supply chains and reshoring of critical pharmaceutical and base chemical production in America,” continued Huizenga. “Pfizer’s decision to invest $70 billion in research and development, as well as domestic manufacturing here in the United States, is critical to achieving this goal. It is my hope that Pfizer will continue its long-standing partnership with Southwest Michigan and make further investments in Kalamazoo County.”

Bill Huizenga has represented Michigan’s 4th district in the U.S. Congress since 2011 and previously served in the Michigan House of Representatives from 2003 to 2009. He was born in Zeeland, Michigan in 1969 and currently resides in Holland. Huizenga graduated from Calvin College in 1991 with a Bachelor of Arts degree.